Scinai Immunotherapeutics Completes Strategic Reorganization to Enhance CDMO Efficiency and Innovation Scinai Immunotherapeutics has finalized a significant corporate restructuring, focusing on enhancing its CDMO capabilities, aiming for growth and innovation in 2026.

Scinai Immunotherapeutics Completes Strategic Reorganization to Enhance CDMO Efficiency and Innovation #None #Jerusalem #Scinai #CDMO #Immunotherapeutics

The Lundquist Institute thrilled to welcome Santosh Kesari, MD, PhD to our team as a TLI Investigator in #CancerBiology and #Immunotherapeutics.

Please join us in extending a warm welcome and celebrating the impactful work ahead! 🚀 Learn more about Dr. Kesari's work: bit.ly/4qE3rfk.

Tomorrow, we'll be at @cruk-si.bsky.social 😁
Say hi to your account manager Yoana, come check out what innovative technologies we have to improve your research and while you're there enter our competition to win @giantmicrobes.bsky.social 🦠

#immunotherapeutics #cancerresearch #cruk #crukscotland

Frontiers | Artificial Intelligence and Machine Learning in the Development of Vaccines and Immunotherapeutics--Yesterday, Today, and Tomorrow The development of vaccines and immunotherapies against infectious diseases and cancers has been one of the significant achievements of medical science in th...

Frontiers | #ArtificialIntelligence and #MachineLearning (#ML) in the Development of #Vaccines and #Immunotherapeutics

www.frontiersin.org/journals/art...

#MedSky #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

#REVIEW 🚨

Miriam Merad & Co ‪@sinaiimmuno.bsky.social‬
outline the molecular basis of #DendriticCell maturation and the mechanisms through which cancer impairs #DC maturation and consider the potential for DC-focused cancer #immunotherapeutics.
📖 ⬇️